This message contains images. If you don't see images, click here to view.
Advertise in this news brief.

Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit |  Histology Marketplace:     

Home   History   Meeting Calendar   Career Center   Certification   Contact Us    



NSH Molecular Pathology Technology & Methods Forum
Oct. 26 - 28 at the Emory Conference Center in Atlanta
NSH has partnered with Targos Inc and AKESOgen Inc to design this unique three-day forum focused on molecular pathology methods and techniques utilizing expert faculty from both the United States and Europe. In-situ hybridization, microarrays and next-generation sequencing techniques are indispensable tools in molecular pathology and clinical diagnostics. This forum is designed to provide participants a theoretical foundation and practical application into the methods and technology involved in localizing DNA sequences and gene transcripts within the interphase nuclei or on whole chromosomes, as well as rapid gene sequencing and expression analyses of a large numbers of target genes simultaneously. Click here to review the three day schedule.

This course is directed toward practicing histotechnologists, pathology assistants and medical technologists, both in academic and private practice institutions, as well as in the pharmaceutical industry, who wish to broaden and/or update their understanding of the technology and the methods involved. Register now!
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

NSH 41st Annual Symposium/Convention coming soon
Join us Aug. 28-Sept. 2 at the 41st NSH Annual Symposium/Convention and participate in the largest educational event of its kind working to advance and promote the histology profession. NSH is the premier source of learning, knowledge and future-oriented research for histology professionals. Attendance provides resources, education, ideas and advocacy to enhance the performance in the laboratory and ultimately the best patient care.

The Symposium/Convention has the working laboratory in mind when planning five educational-packed days of workshops. With so much to offer, you are able to have a flexible, customizable schedule. You can attend one workshop, 12 workshops or even the exhibit hall only. Customize a schedule that fits your time out of the lab and meets your educational and budget needs at the same time. This year we are excited to introduce our 60-minute troubleshooting workshops along with our 90-minute and three-hour sessions. With over 125 unique learning opportunities, we are confident that you will find the format that is right for you.

Sessions & Scientific Exhibits will take place in the Gaylord National Resort & Convention Center. The resort is located in the beautiful waterfront entertainment district only eight miles south of downtown Washington, D.C. NSH has reserved rooms at the Gaylord. Register now.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

  GBI Cost Effective Products

GBI Labs produces the largest selection of secondary detection kits, from single to multiple detection kits, with wide range host species. We provide FREE samples to 1st time users. Staining with our kits results in similar or better sensitivity than other detection kits on the market with 20%-30% cost less.


ICD-10 conversion is now 56 days away and could put financial squeeze on clinical labs and pathology groups
Dark Daily
Conversion to ICD-10 is now only 56 days away! Physicians are not the only ones with a large stake in the conversion from ICD-9 to ICD-10 that takes place Oct. 1. Clinical laboratories and anatomic pathology groups will be watching to see whether physicians include appropriate ICD-10 codes on lab test forms for Medicare patients.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Common class of 'channel blocking' drugs may find a role in cancer therapy
University of California, San Francisco via Medical Xpress
Drugs called ion channel blockers, which are commonly used to treat cardiac, neurological and psychiatric disorders, might prove useful in cancer therapy, according to research findings discovered by UC San Francisco scientists using fruit flies and mice. This research led to unconventional treatment of a case of metastatic brain cancer.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

New hybrid microscope offers awesome capabilities
Lab Manager
A microscope being developed at the Department of Energy's Oak Ridge National Laboratory will allow scientists studying biological and synthetic materials to simultaneously observe chemical and physical properties on and beneath the surface.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Vaccine combo shows promise against common, dangerous infection
Science Translational Medicine via Medical Xpress
Researchers report they are closer to finding a vaccine for respiratory syncytial virus, a common illness that few recognize by name but one that's a major cause of lower respiratory infection in babies and the elderly. Two new studies of the same vaccine combination, one involving people, don't prove that it will work in humans. Still, "they certainly do offer hope for the development of vaccines," said Dr. Peter Openshaw, a senior investigator at the National Institute for Health Research in London, England.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

  Hassle Free Block Storage Cabinet

Avantik Biogroup is proud to introduce another Customer Requested Quality Innovation for Histology...the Avantik Biogroup Block Storage Cabinet! We introduced Hassle-Free Drawer Technology with Interlocking Stackability and More Clearance between the top of the blocks and the drawers to achieve the industry's first Jam-Free, Hassle-Free Block Storage Cabinet!

Low-dose lithium lowers involuntary motor movements in mouse model of Parkinson's disease
Low-dose lithium reduced involuntary motor movements — the troubling side effect of the medication most commonly used to treat Parkinson's disease — in a mouse model of the condition that is diagnosed in about 60,000 Americans each year. The third in a series of studies from the Andersen lab involving Parkinson's disease and low-dose lithium, the results add to mounting evidence that low-doses of the psychotropic drug could benefit patients suffering from the incurable, degenerative condition.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Missed an issue of Under The Microscope? Click here to visit the Under The Microscope archive page.

Congress takes aim at healthcare technology data blocking in a move that might benefit many clinical pathology labs
Dark Daily
Federal health officials are taking steps to end technology vendors' "data blocking" practices that inhibit the electronic transfer of patient information. This is a tactic that has proven costly for pathology groups and clinical laboratories that want to interface their laboratory information systems with providers' or hospitals' electronic healthcare records. The fiscal year 2015 Omnibus Appropriations Bill passed by Congress in December directed the Office of the National Coordinator for Health Information Technology to decertify electronic health record products that are knowingly interfering with the sharing of health information.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Clinical researchers are slow to utilize digital health to help with studies
Many research scientists are not keeping up with the latest developments in mobile technology, according to a recent in-depth review of the medical literature. The review found that investigators who design and implement clinical trials have been slow to adopt mobile devices and the Internet–digital tools that have the potential to improve the research process.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Scientists identify a mechanism of epidemic bacterial disease
Infection Control Today
Through identification of increased toxin production by epidemic forms of group A streptococcus (the "flesh-eating" bacterium), for the first time scientists are able to pinpoint the molecular events that contribute to large intercontinental epidemics of disease. The study was based on sequencing almost 5,000 group A streptococcus genomes collected over decades.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Missed last week's issue? See which articles your colleagues read most.

    How Ebola-vaccine success could reshape clinical-trial policy (Nature)
Lab-inventory management: Time to take stock (Nature)
Fast, accurate genetic tests may soon help doctors tell if you really need antibiotics (Duke University via Medical Xpress)
Neuroblastoma cancer cells weaken immune system 'like kryptonite' (Medical News Today)
Mitochondrial disease research makes progress (The Wall Street Journal)

Don't be left behind. Click here to see what else you missed.


Under the Microscope
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Ashley Whipple, Senior Content Editor, 469.420.2642   
Contribute news

This edition of Under the Microscope was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Aug. 6, 2015 blast
Aug. 5, 2015
July 29, 2015
July 29, 2015 blast

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063